Vanguard Group Inc Palisade Bio, Inc. Transaction History

Vanguard Group Inc

  • $5.46 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$0.11 - $83.85 $21,345 - $16.3 Million
-194,051 Reduced 71.45%
77,553 $8,000
Q1 2022

May 13, 2022
BUY
$0.81 - $1.51 $22,691 - $42,301
28,014 Added 11.5%
271,604 $288,000
Q3 2021

Nov 12, 2021
BUY
$2.35 - $3.93 $13,580 - $22,711
5,779 Added 2.43%
243,590 $645,000
Q2 2021

Aug 13, 2021
BUY
$3.49 - $11.34 $829,960 - $2.7 Million
237,811 New
237,811 $968,000

About PALISADE BIO, INC.

PALI Quotes by TradingView
  • Ticker PALI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,240,200
  • Market Cap $122M
  • Description
  • Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. Its lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzym...
More about PALI
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email